GHOSH ANIRVAN (Chief Executive Officer) sold 0.7% of their position (589.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2023ACC: 0000950170-23-058800
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-589.00
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
589.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−589.00
Price / share
$1.83
Trade value
$1.08K
% of position
0.7%
11/2/2023
81.20K→80.61K
Total
Net shares
−589.00
Net value
-$1.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 11/2/2023 | S · Sale | −589.00 | $1.83 | $1.08K | 0.7% | 81.20K | 80.61K |
| Total | −589.00 | -$1.08K | ||||||
Derivative Transactions0
No derivative transactions reported